Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review - PubMed (original) (raw)
Review
doi: 10.1177/1534735415572883. Epub 2015 Mar 17.
Affiliations
- PMID: 25784670
- DOI: 10.1177/1534735415572883
Free article
Review
Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review
Heidi Fritz et al. Integr Cancer Ther. 2015 May.
Free article
Abstract
Background: Polysaccharide K, also known as PSK or Krestin, is derived from the Coriolus versicolor mushroom and is widely used in Japan as an adjuvant immunotherapy for a variety of cancer including lung cancer. Despite reported benefits, there has been no English language synthesis of PSK for lung cancer. To address this knowledge gap, we conducted a systematic review of PSK for the treatment of lung cancer.
Methods: We searched PubMed, EMBASE, CINAHL, the Cochrane Library, AltHealth Watch, and the Library of Science and Technology from inception to August 2014 for clinical and preclinical evidence pertaining to the safety and efficacy of PSK or other Coriolus versicolor extracts for lung cancer.
Results: Thirty-one reports of 28 studies were included for full review and analysis. Six studies were randomized controlled trials, 5 were nonrandomized controlled trials, and 17 were preclinical studies. Nine of the reports were Japanese language publications. Fifteen of 17 preclinical studies supported anticancer effects for PSK through immunomodulation and potentiation of immune surveillance, as well as through direct tumor inhibiting actions in vivo that resulted in reduced tumor growth and antimetastatic effects. Nonrandomized controlled trials showed improvement of various survival measures including median survival and 1-, 2-, and 5-year survival. Randomized controlled trials showed benefits on a range of endpoints, including immune parameters and hematological function, performance status and body weight, tumor-related symptoms such as fatigue and anorexia, as well as survival. Although there were conflicting results for impact on some of the tumor-related symptoms and median survival, overall most randomized controlled trials supported a positive impact for PSK on these endpoints. PSK was safely administered following and in conjunction with standard radiation and chemotherapy.
Conclusions: PSK may improve immune function, reduce tumor-associated symptoms, and extend survival in lung cancer patients. Larger, more rigorous randomized controlled trials for PSK in lung cancer patients are warranted.
Keywords: Coriolus versicolor; cancer; complementary and alternative medicine; herb-drug interactions; lung cancer; natural health products; polysaccharide K (PSK); polysaccharide peptide (PSP); systematic review.
© The Author(s) 2015.
Similar articles
- Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M, Yang LX. Fisher M, et al. Anticancer Res. 2002 May-Jun;22(3):1737-54. Anticancer Res. 2002. PMID: 12168863 Review. - [Immunomodulatory and antitumor properties of polysaccharide peptide (PSP)].
Piotrowski J, Jędrzejewski T, Kozak W. Piotrowski J, et al. Postepy Hig Med Dosw (Online). 2015 Jan 21;69:91-7. doi: 10.5604/17322693.1137086. Postepy Hig Med Dosw (Online). 2015. PMID: 25614677 Review. Polish. - The use of mushroom glucans and proteoglycans in cancer treatment.
Kidd PM. Kidd PM. Altern Med Rev. 2000 Feb;5(1):4-27. Altern Med Rev. 2000. PMID: 10696116 Review. - [Effect of PSK on recurrence of stage II/III gastric cancer].
Tanaka H, Muguruma K, Kubo N, Amano R, Noda E, Yamada N, Yashiro M, Maeda K, Sawada T, Ohira M, Ishikawa T, Hirakawa K. Tanaka H, et al. Gan To Kagaku Ryoho. 2010 Nov;37(12):2258-60. Gan To Kagaku Ryoho. 2010. PMID: 21224540 Japanese. - Krestin (PSK).
Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K. Tsukagoshi S, et al. Cancer Treat Rev. 1984 Jun;11(2):131-55. doi: 10.1016/0305-7372(84)90005-7. Cancer Treat Rev. 1984. PMID: 6238674 Review.
Cited by
- Arsenic(III)-induced oxidative defense and speciation changes in a wild Trametes versicolor strain.
Zhang Y, Chen X, Wang C, Xia Z, Xiao K, Xie L. Zhang Y, et al. PLoS One. 2023 May 30;18(5):e0286105. doi: 10.1371/journal.pone.0286105. eCollection 2023. PLoS One. 2023. PMID: 37252911 Free PMC article. - Metastatic Cardiac Hemangiosarcoma in a 6 Year Old Wheaten Terrier Mix.
Arai S, Milley EP, Lichtenberger J, Savidge C, Lawrence J, Côté E. Arai S, et al. Vet Sci. 2019 Jul 23;6(3):65. doi: 10.3390/vetsci6030065. Vet Sci. 2019. PMID: 31340545 Free PMC article. - Anticancer potential of grifolin in lung cancer treatment through PI3K/AKT pathway inhibition.
Wang L, Wang Y, Wang Z, Zhang X, Chen H, Lin Q, Wang X, Wen Y, Pan X, Guo Z, Wan B. Wang L, et al. Heliyon. 2024 Apr 9;10(8):e29447. doi: 10.1016/j.heliyon.2024.e29447. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38644824 Free PMC article. - A safety assessment of Coriolus versicolor biomass as a food supplement.
Barros AB, Ferrão J, Fernandes T. Barros AB, et al. Food Nutr Res. 2016 Mar 10;60:29953. doi: 10.3402/fnr.v60.29953. eCollection 2016. Food Nutr Res. 2016. PMID: 26969586 Free PMC article. - The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation.
Monga S, Fares B, Yashaev R, Melamed D, Kahana M, Fares F, Weizman A, Gavish M. Monga S, et al. J Fungi (Basel). 2022 Mar 21;8(3):321. doi: 10.3390/jof8030321. J Fungi (Basel). 2022. PMID: 35330323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous